CLINICAL

EIO Biomedical

PILOT CLINICAL TRIAL

  • Clinical center: Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania

  • Patient population: 30 patients (15 treated with ESC, 15 control)

  • The results indicated that the product was safe, simple to use and easily integrated in the surgical protocol

  • The product did not induce any immediate or long-term adverse effects and a trend of efficacy was demonstrated